Stay updated on Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial

Sign up to get notified when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added 'Gastric cancer' as a condition/topic and included a resources entry for Genetic and Rare Diseases Information Center related to gastric cancer.
    Difference
    0.2%
    Check dated 2026-02-18T04:22:26.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows an administrative Revision: v3.4.2 and removal of a general funding/status notice (including Revision: v3.4.1), which do not affect the study content or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:21:06.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the site to revision v3.4.1 (with v3.4.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:25:01.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary visibility has been enabled on the page. The update history metadata now shows 'Last Update Submitted that Met QC Criteria' and the revision tag has been updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T21:12:44.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Addition: Revision: v3.3.4 and deletion: Revision: v3.3.3 appear in the page footer.
    Difference
    0.1%
    Check dated 2026-01-20T15:31:12.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Kansas under Locations and updated page revision to v3.3.3; removed HHS Vulnerability Disclosure and Kansas Locations.
    Difference
    0.2%
    Check dated 2025-12-22T20:46:45.000Z thumbnail image

Stay in the know with updates to Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.